Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry M Massie

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Journal of Cardiac Failure|October 25, 2002
What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physiciansBarry M Massie
Journal of Cardiac Failure|May 17, 2003
Negative, neutral, and discordant results: what should an editor do?Barry M Massie
Journal of Molecular and Cellular Cardiology|May 10, 2011
Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialistBarry M Massie
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
Prevention of heart failure with chlorthalidone in ALLHAT: placing the results into perspectiveBarry M Massie
Journal of the American College of Cardiology|September 20, 2005
Aspirin use in chronic heart failure: what should we recommend to the practitioner?Barry M Massie
Evidence-Based Medicine|September 22, 2007
Review: Available evidence does not support the use of beta blockers as first line treatment for hypertensionBarry M Massie
The Physician and Sportsmedicine|December 27, 2017
To Combat Hypertension, Increase ActivityBarry M Massie
Journal of the American College of Cardiology|June 12, 2003
Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and badBarry M Massie
European Journal of Heart Failure|June 26, 2010
Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear!Barry M Massie
Journal of Cardiac Failure|October 30, 2003
The dilemma of drug development for heart failure: when is the time to initiate large clinical trials?Barry M Massie
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Journal of Cardiac Failure|October 25, 2002
What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physiciansBarry M Massie
Journal of Cardiac Failure|May 17, 2003
Negative, neutral, and discordant results: what should an editor do?Barry M Massie
Journal of Molecular and Cellular Cardiology|May 10, 2011
Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialistBarry M Massie
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
Prevention of heart failure with chlorthalidone in ALLHAT: placing the results into perspectiveBarry M Massie
Journal of the American College of Cardiology|September 20, 2005
Aspirin use in chronic heart failure: what should we recommend to the practitioner?Barry M Massie
Evidence-Based Medicine|September 22, 2007
Review: Available evidence does not support the use of beta blockers as first line treatment for hypertensionBarry M Massie
The Physician and Sportsmedicine|December 27, 2017
To Combat Hypertension, Increase ActivityBarry M Massie
Journal of the American College of Cardiology|June 12, 2003
Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and badBarry M Massie
European Journal of Heart Failure|June 26, 2010
Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear!Barry M Massie
Journal of Cardiac Failure|October 30, 2003
The dilemma of drug development for heart failure: when is the time to initiate large clinical trials?Barry M Massie
Pageof 15